Recombinant colony-stimulating factors - innovative biotechnologies in cell-therapy of leukopoiesis pathology
Date
2014-05
Authors
Olefir, Alexander
Screbec, Nikolay
Karnaukh, Ella
Journal Title
Journal ISSN
Volume Title
Publisher
ХНМУ
Abstract
The most important innovation of modern biotechnology is creating by genetic engineering of the recombinant human stimulants of leukopoiesis and immunomodulators. This current trend in cell therapy of leukopenia and immunodeficiency disorders of various origins, associated with suppression of bone marrow leukopoietic function.This is a strategic direction of biomedicine for the world medical science and it has become an integral part of the therapeutic arsenal of leading clinics of Germany, USA, Israel and other countries.
Description
Keywords
Sargramostim., recombinant colony-stimulating factors (CSF), granulocyte-CSF (G-CSF), macrophage-CSF (M-CSF), granulocyte-macrophage-CSF (GM-CSF), Filgrastim, Lenograstim (Granocyte), Pegfilgrastim (Neulastim), Molgramostim (Leucomax, Neustim)
Citation
Olefir A. S. Recombinant colony-stimulating factors - innovative biotechnologies in cell-therapy of leukopoiesis pathology / A. S. Olefir, N. S. Skrebec, E. V. Karnaukh // 7th International Scientific Interdisciplinary Conference (ISIC) for medical students and young scientists, Ukraine, 15–16 may 2014 : аbstract book. – Kharkiv : KhNMU, 2014. – P. 203–204.